Weight
CJC-1295 (No Dac)/Ipamorelin
Growth
2
Amino acids
Molecular weight
Blend
Type
A dual-pathway protocol combining CJC-1295 and Ipamorelin that targets growth hormone secretion through complementary mechanisms. CJC-1295 demonstrates 2-10 fold GH increases with 6-8 day duration, while Ipamorelin provides selective GH release without cortisol elevation.
Top researched benefits
Overview of CJC-1295 (No Dac)/Ipamorelin
CJC-1295 activates GHRH receptors via albumin-binding DAC technology for sustained elevation. Ipamorelin selectively activates ghrelin receptors (GHSR1a) without affecting ACTH/cortisol, preserving natural pulsatile GH patterns.
muscle growth
- Growth hormone elevation supports muscle protein synthesis and nitrogen retention during training.
- Sustained GH patterns may accelerate muscle repair between exercise sessions.
- GH optimization helps maintain muscle during caloric restriction or aging.
metabolic health
- Growth hormone promotes lipolysis while supporting lean tissue maintenance.
- Enhanced GH patterns may improve glucose and fat utilization.
antiaging
- Evening GH peaks align with deeper, more restorative sleep patterns.
- Sustained GH elevation supports skin elasticity and connective tissue health.
recovery
- Growth hormone supports tissue repair and recovery from exercise or injury.
- Enhanced collagen synthesis supports joint and connective tissue integrity.
Typical Dose
200-300mcg of each peptide (CJC-1295 and Ipamorelin)
Frequency
Once daily, preferably in the evening
Cycle Duration
8-12 weeks on
Storage
Lyophilized: 2-8°C refrigerated; Reconstituted: 2-8°C refrigerated, use within 30 days
Chemical Makeup
Key benefits
Sustained GH elevation (6-8 days from CJC-1295)
Selective pulsatile release without cortisol suppression
Complementary dual-pathway optimization
Preservation of natural GH rhythm
Enhanced muscle protein synthesis and recovery
Community interest
This peptide is still gaining traction in the community.
GHRH/GHRP Combination | Growth Hormone Optimization
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesNoCJC-1295 (No Dac)/Ipamorelin Molecular Information
View the scientifc details of CJC-1295 (No Dac)/Ipamorelin.
2
Amino Acids
CJC-1295 (No Dac)/Ipamorelin
Asn
Asn
Position 1
Ala
Ala
Position 2
Molecular Weight
0DaChain Length
2Amino AcidsType
BlendCJC-1295 (No Dac)/Ipamorelin Protocols
Subcutaneous administration optimal for bioavailability; available as blended vials or separate formulations.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| General Health Optimization | 200 | 1 week range | SubQ |
| Performance Enhancement | 250 | 1 week range | SubQ |
| Recovery Optimization | 300 | 1 week range | SubQ |
| Conservative Approach | 150 | 5 week range | SubQ |
Reconstitution Instructions
Materials needed:
Steps to reconstitute
- BLENDED: Add 2mL bacteriostatic water to create ~2mg/mL concentration
- SEPARATE: Add 2mL water to each vial for 1mg/mL per peptide
- Draw 0.2-0.3mL for 200-300mcg dosing
- Mix equal volumes or inject at different sites
- Administer 2-3 hours post-meal, 30-60 minutes before bed
- Rotate subcutaneous sites (abdomen, thigh, upper arm) daily
CJC-1295 (No Dac)/Ipamorelin Cycle
The CJC-1295 (No Dac)/Ipamorelin Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
- Week 1-2
- Improved sleep depth and quality; increased dream vividness
- Week 3-4
- Enhanced exercise recovery; reduced muscle soreness; improved energy
- Week 6-8
- Gradual body composition changes; improved skin quality; general well-being
- Week 8-12
- Optimized benefits plateau; individual responses vary significantly
- Week 0-0
- Benefits persist several weeks due to improved sleep and recovery patterns
Dosing tools
CJC-1295 (No Dac)/IpamorelinBlend Dosage Calculator
Calculate blended peptide doses with our visual syringe guide.
Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.
1 mL
2 mL
3 mL
5 mL
Custom
Custom Blend Compounds
Total: 2.0 mg
mg
The dose of the anchor peptide you want per administration, in mcg or mg.
Conversion: 1,000 mcg = 1 mg
Results
Concentration
2.00
mg/mL
Doses per vial
8
Total blend to inject
0.25
mg
You'll get:
- Ipamorelin
- 250 mcgANCHOR
1mL / 100 units
12 units
0.125 mL
Dosing Guidance
Recommended Schedule
Once daily, preferably in the evening
Supply Duration
This vial provides 8 doses (8-day supply at 250 mcg daily)
Peptide Interactions
Research suggestions of CJC-1295 (No Dac)/Ipamorelin interactions with other common peptides and substances.
Healing
bpc
Longevity
BPC-157
COMPATIBLE
No known interactions; different mechanisms (GH optimization vs. tissue repair signaling).
Weight
mk6
Growth
MK-677
MONITOR
Both affect GH pathways; monitor for excessive GH elevation and insulin sensitivity changes.
Side effects
Monitor: Be careful when combining CJC-1295 (No Dac)/Ipamorelin with MK-677.
Contraindications
Cancer history or active malignancy
Severe diabetes requiring tight glucose control
Carpal tunnel syndrome or nerve compression disorders
Stop signs
Persistent joint pain or swelling indicating fluid retention
Significant blood glucose changes or diabetic control issues
Unusual fatigue, lethargy, or mood deterioration
Injection site infections or persistent reactions
Numbness or tingling in hands/feet
Signs of accelerated tumor growth if cancer history exists
Bad signs
Comments
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Frequently asked questions
What is a peptide dosage calculator?
A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.
How do I calculate peptide dosage from a vial?
To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.
How much Bacteriostatic water should I add to a peptide vial?
Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.
How are peptides different from proteins?
Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.
CJC-1295 (No Dac)/IpamorelinResearch References
CJC-1295 (No Dac)/Ipamorelin is a well studied compound
CJC-1295 (No Dac)/Ipamorelin
CJC-1295 (No Dac)/Ipamorelin is a well studied compound
CJC-1295 Clinical Efficacy - Teichman et al.
2-10 fold GH increase, 1.5-3 fold IGF-1 increase with 5.8-8.1 day half-life.
2006
Ipamorelin Selectivity - Raun et al.
First selective GHS with no ACTH/cortisol effects even at 200x effective dose.
1998
GH Pulsatility Preservation - Ionescu & Frohman
CJC-1295 preserves pulsatile GH secretion while increasing basal levels 7.5-fold.
2006
GHRH-GHS Receptor Interaction - Cunha & Mayo
Cellular study demonstrating potentiation of GHRH signaling with GHS receptors present.
2002